CELLULAR REJUVENATION PLATFORM
Restoring the biology of youth, one cell at a time.
Syntic Life is a biotechnology company developing gene therapies that target the underlying biology of aging. Following positive results in mouse models, our lead program is advancing through the preclinical work required to move this science toward the clinic.
Aging is the single largest modifiable risk factor for most chronic disease. A growing body of research shows that cells can be rejuvenated through epigenetic restoration — addressing the root biology of age-related conditions rather than their symptoms alone. By focusing on this one powerful layer of biology, we are building a platform with the potential to renew many tissues and treat many diseases.
As we age, our DNA stays largely the same — but the epigenetic markers that tell each cell which genes to use become disorganized. Syntic Life uses defined reprogramming factors to partially restore these markers, guiding aged cells toward a younger, healthier state while preserving their identity.
Explore the science
Our research is powered by an AI discovery platform built by our sister company, Syntic AI, which runs its own model to identify and prioritize therapeutic targets before they reach the bench.
Meet Syntic AIMouse
Proven in living systems
Syntic Life has demonstrated cellular rejuvenation in mice. In our studies, our lead approach restored markers of cellular age toward a younger state relative to untreated controls, with no adverse safety signals observed at the doses tested.
Platform
Built for many tissues
By focusing on one foundational layer of biology, the platform is designed to support multiple organ-specific programs over time.
Rigorous
Translational focus
Current work is centered on the preclinical studies required to move this science toward the clinic with discipline and reproducibility.
Vision
A future where age-related decline is addressed through precise biological intervention — not accepted as inevitable.
Our vision